Iksuda
We build superior ADCs | Iksuda Therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
€163—245m (Dealroom.co estimates Jun 2021.)
Company register number 06433234
Newcastle upon Tyne England (HQ)
Financials
Estimates*
| GBP | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenues | 3.7m | - | - |
| EBITDA | (3.5m) | (11.3m) | (15.0m) |
| % EBITDA margin | (96 %) | - | - |
| Profit | (3.6m) | (12.5m) | (14.0m) |
| % profit margin | (96 %) | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
£500k | Early VC | ||
£2.0m | Early VC | ||
£700k | Early VC | ||
£34.0m | Late VC | ||
| Total Funding | €44.6m | ||